IVA Quote, Financials, Valuation and Earnings

Cellectis SA has a net margin of -- compared to Inventiva SA's net margin of 1.68%. Inventiva SA's return on equity of -- beat Cellectis SA's return on equity of -31.08%.

Inventiva SA has a consensus price target of $15.48, signalling upside risk potential of 138.58%. On the other hand Cellectis SA has an analysts' consensus of $7.25 which suggests that it could grow by 86.86%. Given that Inventiva SA has higher upside potential than Cellectis SA, analysts believe Inventiva SA is more attractive than Cellectis SA.

Inventiva SA has a beta of 0.708, which suggesting that the stock is 29.202% less volatile than S&P 500. In comparison Cellectis SA has a beta of 2.855, suggesting its more volatile than the S&P 500 by 185.46%.

Inventiva SA has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cellectis SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Inventiva SA pays -- of its earnings as a dividend. Cellectis SA pays out -- of its earnings as a dividend.

Inventiva SA quarterly revenues are --, which are smaller than Cellectis SA quarterly revenues of $35M. Inventiva SA's net income of -- is lower than Cellectis SA's net income of $586.4K. Notably, Inventiva SA's price-to-earnings ratio is -- while Cellectis SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Inventiva SA is 37.78x versus 4.83x for Cellectis SA. Usually stocks with elevated PS ratios are considered overvalued.

DBV Technologies SA has a net margin of -- compared to Inventiva SA's net margin of --. Inventiva SA's return on equity of -- beat DBV Technologies SA's return on equity of -280.59%.

Inventiva SA has a consensus price target of $15.48, signalling upside risk potential of 138.58%. On the other hand DBV Technologies SA has an analysts' consensus of $40.02 which suggests that it could grow by 90.89%. Given that Inventiva SA has higher upside potential than DBV Technologies SA, analysts believe Inventiva SA is more attractive than DBV Technologies SA.

Inventiva SA has a beta of 0.708, which suggesting that the stock is 29.202% less volatile than S&P 500. In comparison DBV Technologies SA has a beta of -0.975, suggesting its less volatile than the S&P 500 by 197.455%.

Inventiva SA has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DBV Technologies SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Inventiva SA pays -- of its earnings as a dividend. DBV Technologies SA pays out -- of its earnings as a dividend.

Inventiva SA quarterly revenues are --, which are smaller than DBV Technologies SA quarterly revenues of --. Inventiva SA's net income of -- is lower than DBV Technologies SA's net income of -$33M. Notably, Inventiva SA's price-to-earnings ratio is -- while DBV Technologies SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Inventiva SA is 37.78x versus -- for DBV Technologies SA. Usually stocks with elevated PS ratios are considered overvalued.

Genfit SA has a net margin of -- compared to Inventiva SA's net margin of --. Inventiva SA's return on equity of -- beat Genfit SA's return on equity of --.

Inventiva SA has a consensus price target of $15.48, signalling upside risk potential of 138.58%. On the other hand Genfit SA has an analysts' consensus of -- which suggests that it could fall by --. Given that Inventiva SA has higher upside potential than Genfit SA, analysts believe Inventiva SA is more attractive than Genfit SA.

Inventiva SA has a beta of 0.708, which suggesting that the stock is 29.202% less volatile than S&P 500. In comparison Genfit SA has a beta of 0.000, suggesting its less volatile than the S&P 500 by 99.966%.

Inventiva SA has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Genfit SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Inventiva SA pays -- of its earnings as a dividend. Genfit SA pays out -- of its earnings as a dividend.

Inventiva SA quarterly revenues are --, which are smaller than Genfit SA quarterly revenues of --. Inventiva SA's net income of -- is lower than Genfit SA's net income of --. Notably, Inventiva SA's price-to-earnings ratio is -- while Genfit SA's PE ratio is 49.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Inventiva SA is 37.78x versus 11.55x for Genfit SA. Usually stocks with elevated PS ratios are considered overvalued.

Nicox SA has a net margin of -- compared to Inventiva SA's net margin of --. Inventiva SA's return on equity of -- beat Nicox SA's return on equity of -43.13%.

Inventiva SA has a consensus price target of $15.48, signalling upside risk potential of 138.58%. On the other hand Nicox SA has an analysts' consensus of -- which suggests that it could fall by --. Given that Inventiva SA has higher upside potential than Nicox SA, analysts believe Inventiva SA is more attractive than Nicox SA.

Inventiva SA has a beta of 0.708, which suggesting that the stock is 29.202% less volatile than S&P 500. In comparison Nicox SA has a beta of -0.051, suggesting its less volatile than the S&P 500 by 105.13%.

Inventiva SA has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nicox SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Inventiva SA pays -- of its earnings as a dividend. Nicox SA pays out -- of its earnings as a dividend.

Inventiva SA quarterly revenues are --, which are smaller than Nicox SA quarterly revenues of --. Inventiva SA's net income of -- is lower than Nicox SA's net income of --. Notably, Inventiva SA's price-to-earnings ratio is -- while Nicox SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Inventiva SA is 37.78x versus 5.89x for Nicox SA. Usually stocks with elevated PS ratios are considered overvalued.